Daptomycin use in infants: Report of two cases with peak and trough drug concentrations

Journal of Perinatology

Volumn 28, Issue 3, 2008, Pages 233-234

  Cohen Wolkowiez, M ^a   Smith, P B ^b   Benjamin, D K ^a,b   Fowler, V G ^a   Wade, K C ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CASE REPORT; CHILD CARE; DRUG BLOOD LEVEL; DRUG USE; FEMALE; HEART ATRIUM SEPTUM DEFECT; HUMAN; INFANT; MALE; MAXIMUM PLASMA CONCENTRATION; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; DRUG MONITORING; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 40349100430     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211898     Document Type: Article

References (3)

1. Fda.gov [homepage on the Internet]. Maryland: Food and Drug Administration 2003, available from: http://www.fda.gov/.
2. Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother 2003; 47(4): 1318-1323.
3. Kearns GL, Jacobs RF, Jafri HS, Hong EF, Benziger DP. Pharmacokinetics of daptomycin in pediatric patients. PAS 2007: Pediatric Academic Societies' Annual Meeting, Toronto; 2007 May 5-8; Toronto,.Canada 2007.